Evidence map›Paper›PMID 33619337›Full record

ArticleScientific reports2021

Modeling COVID-19 epidemics in an Excel spreadsheet to enable first-hand accurate predictions of the pandemic evolution in urban areas.

Mario Moisés Alvarez, Everardo González-González, Grissel Trujillo-de Santiago

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A Spreadsheet-Based Short Time Forecasting Method for the COVID-19 Pandemic.Transactions of the Indian National Academy of Engineering : an international journal of engineering and technology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mario Moisés AlvarezCentro de Biotecnología-FEMSA, Tecnologico de Monterrey, 64849, Monterrey, NL, Mexico. mario.alvarez@tec.mx.
Everardo González-GonzálezCentro de Biotecnología-FEMSA, Tecnologico de Monterrey, 64849, Monterrey, NL, Mexico.
Grissel Trujillo-de SantiagoCentro de Biotecnología-FEMSA, Tecnologico de Monterrey, 64849, Monterrey, NL, Mexico.

Funding

Consejo Nacional de Ciencia y Tecnología CONACYTInstituto Tecnológico y de Estudios Superiores de Monterrey GIEE 002EICIN01
6 · The paper itself

Abstract

COVID-19, the first pandemic of this decade and the second in less than 15 years, has harshly taught us that viral diseases do not recognize boundaries; however, they truly do discriminate between aggressive and mediocre containment responses. We present a simple epidemiological model that is amenable to implementation in Excel spreadsheets and sufficiently accurate to reproduce observed data on the evolution of the COVID-19 pandemics in different regions [i.e., New York City (NYC), South Korea, Mexico City]. We show that the model can be adapted to closely follow the evolution of COVID-19 in any large city by simply adjusting parameters related to demographic conditions and aggressiveness of the response from a society/government to epidemics. Moreover, we show that this simple epidemiological simulator can be used to assess the efficacy of the response of a government/society to an outbreak. The simplicity and accuracy of this model will greatly contribute to democratizing the availability of knowledge in societies regarding the extent of an epidemic event and the efficacy of a governmental response.

Indexed as

COVID-19Disease OutbreaksEpidemicsHumansMexicoNew York CityPandemicsRepublic of KoreaSARS-CoV-2

Identifiers

PMID33619337
PMCPMC7900250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.